Clinical Outcome of Anticoagulant Treatment in Head or Neck Infection-Associated Cerebral Venous Thrombosis

Stroke

Volumn 47, Issue 5, 2016, Pages 1271-1277

  Zuurbier, Susanna M ^a   Coutinho, Jonathan M ^a   Stam, Jan ^a   Canhão, Patricia ^b   Barinagarrementeria, Fernando ^c   Bousser, Marie Germaine ^d   Ferro, José M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

heparin; infection; intracranial hemorrhages; prospective studies; sinus thrombosis, intracranial

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; CEREBRAL SINUS THROMBOSIS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DETERIORATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD AND NECK INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; CENTRAL NERVOUS SYSTEM INFECTION; CHEMICALLY INDUCED; COMPLICATION; EAR NOSE THROAT DISEASE; HEAD; INFECTION; INTRACRANIAL THROMBOSIS; MIDDLE AGED; NECK; PATHOLOGY; SKIN INFECTION; VENOUS THROMBOSIS; YOUNG ADULT;

ADULT; ANTICOAGULANTS; CENTRAL NERVOUS SYSTEM INFECTIONS; FEMALE; HEAD; HEPARIN; HUMANS; INFECTION; INTRACRANIAL HEMORRHAGES; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; NECK; OTORHINOLARYNGOLOGIC DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); SKIN DISEASES, INFECTIOUS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84962128006     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011875     Document Type: Article

References (28)

1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-1798. doi: 10.1056/NEJMra042354.
2. Coutinho JM. Cerebral venous thrombosis. J Thromb Haemost. 2015;13(suppl 1):S238-S244. doi: 10.1111/jth.12945.
3. Krayenbühl HA. Cerebral venous and sinus thrombosis. Neurol Med Chir (Tokyo). 1968;10:1-24.
4. Gates PC. Cerebral venous thrombosis. A retrospective review. Aust N Z J Med. 1986;16:766-770.
5. Karabudak R, Caner H, Oztekin N, Ozcan OE, Zileli T. Thrombosis of intracranial venous sinuses: aetiology, clinical findings and prognosis of 56 patients. J Neurosurg Sci. 1990;34:117-121.
6. Bradshaw P. Benign intracranial hypertension. J Neurol Neurosurg Psychiatry. 1956;19:28-41.
7. Gowers WR. Thrombosis in the cerebral veins and sinuses. In: Gowers WR, ed. Manual of Diseases of the Nervous System. 2nd ed. London: J&A Churchill; 1893:450-456.
8. Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke. 2014;45:1338-1341. doi: 10.1161/STROKEAHA.113.004666.
9. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
10. Einhäupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
11. Nagaraja D, Rao BS, Taly AB, Subhash MN. Randomized controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. Nat Instit Ment Health Neurosci J. 1995;13:111-115.
12. Coutinho J, de Bruijn SF, Deveber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database Syst Rev. 2011;(8):CD002005.
13. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158-1192. doi: 10.1161/STR.0b013e31820a8364.
14. Einhäupl K, Stam J, Bousser MG, De Bruijn SF, Ferro JM, Martinelli I, et al; European Federation of Neurological Societies. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17:1229-1235. doi: 10.1111/j.1468-1331.2010.03011.x.
15. Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, et al. Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care. 2005;9:R331-R343. doi: 10.1186/cc3538.
16. MacFarlane JT, Cleland PG, Attai ED, Greenwood BM. Failure of heparin to alter the outcome of pneumococcal meningitis. Br Med J. 1977;2:1522.
17. Southwick FS, Richardson EP Jr, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore). 1986;65:82-106.
18. Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology. 1988;38:517-522.
19. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670. doi: 10.1161/01. STR.0000117571.76197.26.
20. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e419S-e494S. doi: 10.1378/chest.11-2301.
21. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-1725. doi: 10.1161/01.STR.0000173152.84438.1c.
22. Dentali F, Poli D, Scoditti U, Di Minno MN, De Stefano V, Stefano VD, et al; CErebral VEin Thrombosis International Study Investigators. Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost. 2012;10:1297-1302. doi: 10.1111/j.1538-7836.2012.04774.x.
23. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 2008;39:2707-2711. doi: 10.1161/STROKEAHA.107.512814.
24. Borhani Haghighi A, Edgell RC, Cruz-Flores S, Feen E, Piriyawat P, Vora N, et al. Mortality of cerebral venous-sinus thrombosis in a large national sample. Stroke. 2012;43:262-264. doi: 10.1161/STROKEAHA.111.635664.
25. Vergouwen MD, Schut ES, Troost D, van de Beek D. Diffuse cerebral intravascular coagulation and cerebral infarction in pneumococcal meningitis. Neurocrit Care. 2010;13:217-227. doi: 10.1007/s12028-010-9387-5.
26. Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Bousser MG, Stam J; ISCVT Investigators. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41:2575-2580. doi: 10.1161/STROKEAHA.110.588822.
27. Mook-Kanamori BB, Fritz D, Brouwer MC, van der Ende A, van de Beek D. Intracerebral hemorrhages in adults with community associated bacterial meningitis in adults: should we reconsider anticoagulant therapy? PLoS One. 2012;7:e45271. doi: 10.1371/journal.pone.0045271.
28. de Veber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001;345:417-423. doi: 10.1056/NEJM200108093450604.